13.43BMarket Cap-79.17P/E (TTM)
19.299High17.980Low1.71MVolume19.010Open19.280Pre Close31.28MTurnover1.49%Turnover RatioLossP/E (Static)737.45MShares33.89052wk High30.66P/B2.09BFloat Cap2.10052wk Low--Dividend TTM114.94MShs Float33.890Historical High--Div YieldTTM6.84%Amplitude0.660Historical Low18.259Avg Price1Lot Size
Summit Therapeutics Stock Forum
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet